Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by
the United States Food and Drug Administration (USFDA) for Fingolimod
Capsules, 0.5 mg, the generic version of Gilenya capsules, 0.5 mg, of
Novartis Pharmaceuticals Corporation," the drug major said in a filing
to BSE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceuticals-gets-usfda-nod-for-fingolimod-capsules/articleshow/76457494.cms
the United States Food and Drug Administration (USFDA) for Fingolimod
Capsules, 0.5 mg, the generic version of Gilenya capsules, 0.5 mg, of
Novartis Pharmaceuticals Corporation," the drug major said in a filing
to BSE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceuticals-gets-usfda-nod-for-fingolimod-capsules/articleshow/76457494.cms
Comments
Post a Comment